Cargando…

Opportunities for improving triple‐negative breast cancer outcomes: results of a population‐based study

Triple‐negative breast cancer (TNBC) is associated with a poor prognosis. Surgery, radiotherapy, chemotherapy, and referral for genetic counseling are the standard of care. We assessed TNBC prevalence, management, and outcome using data from the population‐based Geneva cancer registry. 2591 women ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rapiti, Elisabetta, Pinaud, Kim, Chappuis, Pierre O., Viassolo, Valeria, Ayme, Aurélie, Neyroud‐Caspar, Isabelle, Usel, Massimo, Bouchardy, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345677/ https://www.ncbi.nlm.nih.gov/pubmed/28211614 http://dx.doi.org/10.1002/cam4.998

Ejemplares similares

Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study
por: Retèl, Valesca P, et al.
Publicado: (2014)

Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study
por: Rapiti, Elisabetta, et al.
Publicado: (2013)

A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland
por: Schaffar, Robin, et al.
Publicado: (2019)

Cancer registries can provide evidence-based data to improve quality of care and prevent cancer deaths
por: Bouchardy, Christine, et al.
Publicado: (2014)

Planning for the future: cancer incidence projections in Switzerland up to 2019
por: Rapiti, Elisabetta, et al.
Publicado: (2014)

Recent increase of breast cancer incidence among women under the age of forty
por: Bouchardy, C, et al.
Publicado: (2007)

Cohort profile: population-based cohorts of patients with colorectal cancer and of their relatives in Geneva, Switzerland
por: Benhamou, Simone, et al.
Publicado: (2022)

Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer
por: de Paula, Bruno, et al.
Publicado: (2023)

Testicular cancer in Geneva, Switzerland, 1970–2012: incidence trends, survival and risk of second cancer
por: Schaffar, Robin, et al.
Publicado: (2019)

Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice
por: Bouchardy, C, et al.
Publicado: (2001)

Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature
por: Hu-Heimgartner, Ketty, et al.
Publicado: (2023)

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
por: De Talhouet, Solene, et al.
Publicado: (2020)

Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers
por: Abd El-Aziz, Yomna S., et al.
Publicado: (2021)

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
por: Talhouet, Solene De, et al.
Publicado: (2020)

Cervical cancer screening in Switzerland: cross-sectional trends (1992–2012) in social inequalities
por: Burton-Jeangros, Claudine, et al.
Publicado: (2017)

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
por: Zhang, Haomeng, et al.
Publicado: (2021)

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
por: Vinet, Mathilde, et al.
Publicado: (2019)

The hedgehog pathway in triple‐negative breast cancer
por: Habib, Joyce G., et al.
Publicado: (2016)

Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis
por: Zhao, Cui-Cui, et al.
Publicado: (2021)

Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
por: Xu, Yonggang, et al.
Publicado: (2021)

Two activating mutations of MPL in triple‐negative myeloproliferative neoplasms
por: Xie, Juan, et al.
Publicado: (2019)

Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study
por: Verkooijen, H M, et al.
Publicado: (2006)

Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
por: Weichhaus, Michael, et al.
Publicado: (2014)

Fascin‐1 as a novel diagnostic marker of triple‐negative breast cancer
por: Wang, Chao‐Qun, et al.
Publicado: (2016)

Early-stage Triple-negative Breast Cancer: Time to Optimize Personalized Strategies
por: Abuhadra, Nour, et al.
Publicado: (2022)

Early‐onset triple‐negative breast cancer in multiracial/ethnic populations: Distinct trends of prevalence of truncation mutations
por: Liu, Qian, et al.
Publicado: (2019)

Expression and function of SLC38A5, an amino acid-coupled Na(+)/H(+) exchanger, in triple-negative breast cancer and its relevance to macropinocytosis
por: Ramachandran, Sabarish, et al.
Publicado: (2021)

Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations
por: Ming, Chang, et al.
Publicado: (2020)

Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models
por: Ming, Chang, et al.
Publicado: (2019)

Letter to the editor: Response to Giardiello D, Antoniou AC, Mariani L, Easton DF, Steyerberg EW
por: Ming, Chang, et al.
Publicado: (2020)

NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway
por: Zheng, Qiao, et al.
Publicado: (2020)

Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study
por: Litton, Jennifer K, et al.
Publicado: (2023)

Socioeconomic and demographic inequalities in stage at diagnosis and survival among colorectal cancer patients: evidence from a Swiss population‐based study
por: Feller, Anita, et al.
Publicado: (2018)

Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple-negative breast cancer
por: Bao, Jean, et al.
Publicado: (2015)

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer
por: Ding, Xiaorong, et al.
Publicado: (2020)

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
por: Fang, Wentong, et al.
Publicado: (2021)

Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy
por: Vernaci, Grazia, et al.
Publicado: (2023)

MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018)

Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway
por: Liu, Mian, et al.
Publicado: (2022)

A new bioinformatics tool to help assess the significance of BRCA1 variants
por: Cusin, Isabelle, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e9bst2s7slvvdijp97u2a7mc2b